Trial Profile
A randomized, double blind study of pregabalin in patients with fibromyalgia syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jan 2017
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Fibromyalgia
- Focus Therapeutic Use
- 10 Jan 2017 New trial record
- 16 Nov 2016 Results presented at the 80th American College of Rheumatology and the 51st Annual Meeting of the Association of Rheumatology and Health Professionals.